Peter T. Scardino, MD, FACS | Authors


Validation of a 46-Gene CCP RNA Signature for Predicting Prostate Cancer Death

May 21, 2014

Peter T. Scardino, MD, FACS, discusses an analysis presented at the 2014 AUA Annual Meeting: Validation of a 46-gene cell cycle progression (CCP) RNA signature for predicting prostate cancer death in a conservatively managed watchful waiting needle biopsy cohort.